NPI: 1932184322 · DUBLIN, OH 43016 · Clinical Medical Laboratory · NPI assigned 12/08/2005
Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | WILLIAMS, KIMBERLY (VP) |
| NPI Enumeration Date | 12/08/2005 |
Other providers sharing the same authorized official: WILLIAMS, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,541,487 | $57.30M |
| 2019 | 6,168,640 | $66.25M |
| 2020 | 6,648,674 | $84.06M |
| 2021 | 9,000,405 | $119.19M |
| 2022 | 8,919,542 | $108.62M |
| 2023 | 9,359,792 | $101.56M |
| 2024 | 7,823,460 | $80.02M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 921,196 | 802,422 | $62.80M |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1,241,898 | 1,112,473 | $44.84M |
| 80050 | General health panel | 957,294 | 864,325 | $28.39M |
| 80053 | Comprehensive metabolic panel | 3,831,698 | 3,441,905 | $26.94M |
| 84443 | Thyroid stimulating hormone (TSH) | 2,431,035 | 2,202,706 | $26.89M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,790,274 | 1,614,330 | $25.73M |
| 80061 | Lipid panel | 3,464,440 | 3,143,228 | $24.59M |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 62,806 | 55,991 | $20.96M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3,528,193 | 3,150,958 | $17.15M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 520,757 | 473,164 | $16.40M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 518,903 | 468,885 | $16.27M |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,794,998 | 2,530,469 | $15.63M |
| 86480 | 344,705 | 312,958 | $14.84M | |
| 80081 | 211,607 | 189,007 | $10.84M | |
| 80074 | 369,050 | 327,189 | $9.91M | |
| 86803 | 822,490 | 740,766 | $8.88M | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,376,635 | 1,236,223 | $8.39M |
| 82607 | 928,814 | 842,569 | $8.25M | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 505,318 | 433,713 | $7.93M |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 333,856 | 299,783 | $7.68M |
| 84439 | 1,207,246 | 1,091,874 | $7.46M | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 36,855 | 31,574 | $7.29M |
| 82746 | 619,168 | 559,382 | $5.27M | |
| 83655 | 499,062 | 463,140 | $4.90M | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 140,671 | 124,797 | $4.64M |
| 87902 | 25,757 | 23,551 | $4.21M | |
| 87536 | 69,601 | 64,313 | $4.11M | |
| 84403 | 241,298 | 217,575 | $4.10M | |
| 87522 | Neg quan hep c or qual rna | 157,016 | 142,718 | $4.10M |
| 82728 | 514,692 | 466,612 | $4.08M | |
| 86235 | 61,692 | 55,371 | $4.06M | |
| 87340 | 429,165 | 386,960 | $3.36M | |
| 84153 | 298,578 | 271,113 | $3.35M | |
| 36415 | Collection of venous blood by venipuncture | 1,702,047 | 1,470,480 | $3.16M |
| 85027 | 678,299 | 609,021 | $3.08M | |
| 83550 | 508,379 | 459,423 | $2.91M | |
| 86592 | 864,925 | 777,332 | $2.80M | |
| 87186 | 437,612 | 399,061 | $2.80M | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 60,457 | 39,796 | $2.70M |
| 83013 | 79,491 | 72,750 | $2.59M | |
| 84702 | 278,234 | 213,903 | $2.56M | |
| 87088 | 422,354 | 384,726 | $2.50M | |
| 83540 | 573,364 | 517,403 | $2.45M | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 21,268 | 19,058 | $2.45M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 52,102 | 45,351 | $2.44M |
| 83001 | 169,845 | 153,881 | $2.25M | |
| 87081 | 447,905 | 413,613 | $2.16M | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 21,536 | 19,527 | $2.14M |
| 86003 | 41,719 | 37,349 | $2.11M | |
| 82570 | 593,364 | 538,120 | $2.11M | |
| 84146 | 167,878 | 150,074 | $2.09M | |
| 82043 | 573,916 | 523,057 | $2.08M | |
| 84402 | 127,380 | 114,614 | $2.07M | |
| 86706 | 254,407 | 229,207 | $2.06M | |
| 87150 | 102,568 | 94,348 | $2.02M | |
| 86038 | 226,133 | 204,020 | $1.98M | |
| 86780 | 196,837 | 180,242 | $1.97M | |
| 80048 | Basic metabolic panel (calcium, ionized) | 379,432 | 334,988 | $1.95M |
| 82670 | 115,774 | 104,721 | $1.93M | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 16,559 | 14,630 | $1.77M |
| 83970 | 78,444 | 71,581 | $1.73M | |
| 86787 | 158,190 | 141,751 | $1.72M | |
| 86696 | 113,981 | 101,088 | $1.70M | |
| 81001 | 740,318 | 660,283 | $1.66M | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 36,202 | 32,825 | $1.59M |
| 84481 | 155,978 | 140,881 | $1.58M | |
| 84436 | 344,815 | 311,304 | $1.51M | |
| 87070 | 263,921 | 243,615 | $1.49M | |
| 86704 | 171,764 | 154,685 | $1.49M | |
| 83002 | 131,406 | 118,622 | $1.47M | |
| 87077 | 296,319 | 271,857 | $1.41M | |
| 83735 | 345,099 | 301,450 | $1.41M | |
| 86769 | 36,200 | 31,089 | $1.40M | |
| 86360 | 42,956 | 38,942 | $1.21M | |
| 83880 | 70,164 | 62,480 | $1.21M | |
| 82274 | 118,394 | 109,143 | $1.16M | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 17,467 | 15,865 | $1.15M |
| 84144 | 85,675 | 72,173 | $1.06M | |
| 86695 | 107,321 | 95,136 | $1.04M | |
| 86140 | 295,860 | 263,720 | $1.02M | |
| 86762 | 116,111 | 104,844 | $1.02M | |
| 84479 | 241,712 | 218,161 | $1.00M | |
| 86376 | 110,619 | 99,700 | $987K | |
| 86708 | 114,765 | 103,264 | $934K | |
| 82950 | 254,442 | 232,630 | $917K | |
| 81329 | 20,602 | 18,588 | $916K | |
| 82784 | 94,135 | 83,667 | $834K | |
| 83525 | 107,492 | 97,396 | $814K | |
| 86850 | 135,513 | 123,025 | $784K | |
| 86677 | 38,945 | 34,603 | $728K | |
| 84480 | 80,795 | 72,744 | $726K | |
| 83516 | 54,401 | 48,002 | $721K | |
| 86665 | 32,660 | 29,311 | $699K | |
| 87901 | 4,042 | 3,722 | $698K | |
| 86705 | 78,690 | 70,221 | $671K | |
| 84550 | 228,163 | 204,248 | $669K | |
| 87480 | 41,899 | 38,533 | $666K | |
| 86431 | 152,898 | 138,944 | $663K | |
| 80076 | 123,841 | 110,534 | $647K | |
| 82627 | 48,170 | 43,516 | $640K | |
| 87510 | 41,715 | 38,354 | $640K | |
| 86800 | 64,301 | 58,123 | $634K | |
| 85652 | 309,279 | 276,745 | $617K | |
| 87660 | 41,937 | 38,522 | $611K | |
| 83690 | 129,611 | 117,109 | $604K | |
| 86225 | 63,313 | 57,482 | $578K | |
| 82951 | 59,742 | 55,090 | $567K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 21,352 | 19,355 | $551K |
| 83021 | 42,860 | 38,352 | $529K | |
| 86200 | 61,288 | 56,437 | $523K | |
| 80055 | 15,251 | 14,029 | $515K | |
| 86735 | 50,511 | 45,461 | $499K | |
| 82248 | 162,778 | 144,630 | $497K | |
| 83020 | 57,223 | 51,386 | $495K | |
| 86361 | 34,581 | 31,100 | $491K | |
| 82652 | 29,223 | 25,827 | $485K | |
| 86618 | 32,984 | 29,717 | $466K | |
| 82565 | 170,194 | 149,777 | $461K | |
| 85610 | 168,743 | 134,423 | $453K | |
| 87900 | 5,019 | 4,596 | $448K | |
| 82150 | 102,661 | 92,187 | $448K | |
| 86765 | 54,169 | 48,813 | $443K | |
| 84450 | 156,943 | 139,389 | $435K | |
| 84460 | 146,762 | 130,144 | $433K | |
| 86147 | 12,249 | 10,909 | $422K | |
| 84681 | 33,645 | 30,635 | $417K | |
| 82105 | 37,543 | 33,710 | $417K | |
| 87209 | 33,960 | 30,356 | $413K | |
| 85018 | 203,943 | 186,530 | $395K | |
| 87535 | 15,113 | 13,753 | $392K | |
| 86160 | 28,964 | 25,707 | $389K | |
| 80164 | 55,929 | 49,073 | $386K | |
| 82550 | 93,540 | 82,453 | $374K | |
| 82977 | 83,840 | 73,885 | $366K | |
| 82533 | 34,637 | 30,948 | $363K | |
| 87563 | 20,425 | 18,786 | $352K | |
| 87906 | 3,828 | 3,519 | $347K | |
| 87521 | Neg quan hep c or qual rna | 14,547 | 13,791 | $346K |
| 87075 | 50,978 | 46,889 | $345K | |
| 84520 | 146,817 | 129,507 | $333K | |
| 85660 | 77,957 | 69,641 | $327K | |
| 86317 | 39,882 | 35,548 | $326K | |
| 82947 | 129,198 | 115,573 | $322K | |
| 87255 | 13,851 | 12,728 | $322K | |
| 86364 | 32,316 | 29,066 | $315K | |
| 84075 | 122,036 | 108,889 | $312K | |
| 84154 | 29,057 | 26,343 | $307K | |
| 86709 | 43,974 | 39,190 | $307K | |
| 86901 | 108,924 | 98,618 | $302K | |
| 85014 | 154,746 | 141,516 | $302K | |
| 82040 | 115,820 | 103,280 | $299K | |
| 81596 | 13,751 | 12,492 | $298K | |
| 82247 | 116,516 | 103,400 | $295K | |
| 81003 | 165,098 | 147,874 | $294K | |
| 85730 | 73,642 | 64,377 | $292K | |
| 82310 | 115,875 | 103,590 | $290K | |
| 83615 | 77,736 | 66,918 | $284K | |
| 83721 | 52,286 | 47,230 | $280K | |
| 82785 | 28,918 | 26,099 | $276K | |
| 86900 | 108,906 | 98,613 | $275K | |
| 86664 | 26,638 | 23,953 | $274K | |
| 86334 | 20,337 | 18,334 | $274K | |
| 82672 | 18,843 | 17,202 | $270K | |
| 84156 | 119,806 | 105,062 | $267K | |
| 84445 | 8,033 | 7,482 | $259K | |
| 84155 | 124,141 | 111,155 | $257K | |
| 87517 | 7,740 | 7,225 | $256K | |
| 84703 | 46,867 | 41,726 | $253K | |
| 85045 | 95,451 | 86,173 | $252K | |
| 84425 | 18,663 | 17,156 | $249K | |
| 86146 | 6,113 | 5,468 | $246K | |
| 84100 | 90,359 | 77,185 | $245K | |
| 83498 | 15,230 | 13,995 | $244K | |
| 87427 | 28,426 | 26,167 | $243K | |
| 82024 | 10,409 | 9,519 | $241K | |
| 84295 | 101,727 | 90,830 | $235K | |
| 84165 | 35,951 | 32,567 | $234K | |
| 82435 | 101,161 | 90,470 | $227K | |
| 82140 | 27,976 | 24,487 | $223K | |
| 86870 | 11,993 | 10,570 | $221K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4,527 | 4,153 | $218K |
| 80069 | 43,831 | 38,676 | $216K | |
| 86141 | 23,883 | 21,002 | $215K | |
| 82378 | 20,297 | 17,614 | $212K | |
| 87177 | 34,178 | 30,535 | $209K | |
| 87045 | 28,371 | 26,163 | $208K | |
| 81374 | 7,000 | 6,586 | $207K | |
| 87650 | 12,140 | 11,466 | $202K | |
| 86304 | 15,276 | 13,433 | $201K | |
| 83921 | 16,814 | 15,564 | $195K | |
| 80362 | 15,632 | 6,532 | $192K | |
| 86008 | 6,903 | 6,387 | $186K | |
| 84207 | 10,531 | 9,582 | $177K | |
| 82330 | 20,183 | 17,889 | $173K | |
| 86702 | 21,186 | 18,551 | $169K | |
| 80348 | 25,071 | 14,610 | $166K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 2,505 | 2,268 | $166K |
| 86255 | 19,445 | 17,616 | $164K | |
| 80178 | 37,740 | 32,629 | $157K | |
| 88185 | 625 | 592 | $157K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6,203 | 5,507 | $157K |
| 84270 | 12,317 | 11,100 | $157K | |
| 81243 | 10,412 | 9,461 | $154K | |
| 83090 | 16,459 | 14,394 | $153K | |
| 86258 | 11,871 | 10,795 | $152K | |
| 87529 | 5,119 | 4,636 | $150K | |
| 82952 | 47,962 | 44,503 | $150K | |
| 84132 | 58,773 | 52,334 | $150K | |
| 84466 | 19,473 | 17,557 | $149K | |
| 86231 | 19,794 | 17,861 | $149K | |
| 87046 | 28,704 | 26,301 | $148K | |
| 83521 | 7,182 | 6,386 | $146K | |
| 86300 | 10,501 | 9,284 | $146K | |
| 82465 | 47,029 | 42,690 | $145K | |
| 85379 | 22,913 | 20,252 | $145K | |
| 83520 | 16,274 | 14,965 | $144K | |
| 80051 | 35,061 | 31,064 | $143K | |
| 86593 | 45,859 | 40,980 | $143K | |
| 86757 | 5,989 | 5,648 | $138K | |
| 81257 | 2,533 | 2,367 | $134K | |
| 87350 | 14,178 | 12,961 | $130K | |
| 87324 | 16,244 | 14,869 | $128K | |
| 86701 | 18,044 | 15,653 | $128K | |
| 82374 | 56,262 | 50,413 | $125K | |
| 83718 | 24,436 | 20,891 | $124K | |
| 86663 | 10,853 | 9,783 | $119K | |
| 82626 | 6,727 | 6,203 | $114K | |
| 84305 | 7,610 | 7,130 | $110K | |
| 82088 | 4,005 | 3,756 | $110K | |
| G0307 | Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) | 24,414 | 22,105 | $109K |
| 86359 | 5,534 | 5,031 | $107K | |
| 86707 | 12,262 | 11,189 | $105K | |
| 81361 | 2,737 | 2,560 | $105K | |
| 86341 | 5,516 | 4,995 | $103K | |
| 82239 | 8,012 | 6,811 | $102K | |
| 87338 | 8,585 | 8,111 | $99K | |
| 82103 | 11,795 | 10,647 | $98K | |
| 86060 | 19,186 | 17,618 | $96K | |
| 84134 | 11,753 | 10,542 | $95K | |
| 80185 | 12,963 | 11,373 | $91K | |
| 83883 | 11,724 | 10,454 | $90K | |
| 87493 | 3,897 | 3,593 | $89K | |
| 80177 | 12,677 | 11,711 | $88K | |
| 82172 | 7,843 | 7,129 | $87K | |
| 87538 | 3,307 | 2,966 | $86K | |
| 86617 | 4,324 | 3,891 | $85K | |
| 86381 | 5,756 | 5,258 | $84K | |
| 86301 | 6,824 | 5,851 | $84K | |
| 82397 | 9,399 | 8,452 | $81K | |
| 84432 | 7,273 | 6,775 | $81K | |
| 82390 | 11,576 | 10,246 | $80K | |
| 86645 | 7,111 | 6,394 | $79K | |
| 81381 | 1,888 | 1,766 | $78K | |
| 84630 | 10,647 | 9,763 | $77K | |
| 84482 | 9,772 | 8,809 | $77K | |
| 86644 | 8,116 | 7,220 | $77K | |
| 86256 | 5,120 | 4,497 | $74K | |
| 86336 | 5,218 | 4,653 | $73K | |
| 83010 | 9,298 | 8,352 | $72K | |
| 86694 | 7,197 | 6,447 | $72K | |
| 82677 | 5,186 | 4,616 | $71K | |
| 81255 | 2,914 | 2,730 | $71K | |
| 80156 | 9,343 | 8,430 | $67K | |
| 81251 | 2,897 | 2,712 | $66K | |
| 86671 | 5,009 | 4,636 | $65K | |
| 81200 | 2,922 | 2,730 | $65K | |
| 81241 | 3,356 | 3,060 | $64K | |
| 82164 | 6,802 | 6,261 | $64K | |
| 85246 | 4,740 | 4,304 | $64K | |
| 87184 | 11,448 | 10,544 | $64K | |
| 80361 | 7,317 | 6,955 | $64K | |
| 85245 | 4,699 | 4,274 | $64K | |
| 87329 | 7,623 | 7,026 | $63K | |
| 81330 | 2,896 | 2,712 | $63K | |
| 84484 | 9,735 | 8,514 | $63K | |
| 80197 | 10,172 | 6,915 | $62K | |
| 86037 | 4,056 | 3,751 | $62K | |
| 80349 | 8,628 | 4,643 | $62K | |
| 86335 | 3,492 | 3,196 | $62K | |
| 84410 | 1,903 | 1,744 | $61K | |
| 84166 | 5,901 | 5,369 | $61K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,052 | 925 | $60K |
| 86015 | 6,971 | 6,398 | $58K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 24,807 | 23,582 | $58K |
| 86747 | 2,953 | 2,703 | $55K | |
| 86308 | 14,549 | 13,192 | $55K | |
| 81260 | 2,916 | 2,730 | $54K | |
| 81290 | 2,891 | 2,707 | $54K | |
| 82525 | 6,672 | 6,147 | $54K | |
| 87101 | 9,887 | 9,114 | $54K | |
| 86777 | 5,571 | 4,913 | $53K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 3,470 | 3,386 | $52K |
| 84080 | 6,319 | 5,822 | $52K | |
| 81242 | 2,892 | 2,707 | $52K | |
| 82787 | 3,146 | 2,830 | $51K | |
| 82668 | 5,187 | 4,708 | $50K | |
| 83704 | 2,744 | 2,488 | $50K | |
| 81401 | 1,464 | 1,288 | $49K | |
| 82747 | 5,071 | 4,518 | $48K | |
| 85240 | 4,717 | 4,278 | $47K | |
| 86162 | 3,599 | 3,298 | $47K | |
| 82731 | 997 | 885 | $47K | |
| 84244 | 3,102 | 2,910 | $46K | |
| 81490 | 1,210 | 1,149 | $46K | |
| 82552 | 6,171 | 5,572 | $46K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2,502 | 2,445 | $45K |
| 82553 | 6,828 | 6,135 | $45K | |
| 80353 | 8,485 | 7,783 | $44K | |
| 80171 | 3,731 | 3,504 | $43K | |
| 84590 | 6,100 | 5,595 | $43K | |
| 87205 | 15,151 | 13,720 | $43K | |
| 80165 | 6,236 | 5,591 | $43K | |
| 86778 | 3,849 | 3,503 | $43K | |
| 81209 | 2,917 | 2,724 | $42K | |
| 80324 | 6,770 | 5,886 | $42K | |
| 80299 | 2,730 | 2,492 | $42K | |
| 86666 | 2,222 | 2,088 | $42K | |
| 83014 | 6,655 | 5,934 | $41K | |
| 82679 | 2,748 | 2,470 | $41K | |
| 82157 | 2,065 | 1,921 | $41K | |
| 81025 | 9,503 | 8,051 | $40K | |
| 80354 | 8,091 | 7,449 | $39K | |
| 84446 | 4,297 | 3,964 | $39K | |
| 80359 | 7,456 | 7,053 | $38K | |
| 80175 | 4,604 | 4,234 | $37K | |
| 83527 | 4,119 | 3,839 | $36K | |
| 83993 | 3,057 | 2,883 | $36K | |
| 85007 | 14,073 | 12,868 | $36K | |
| 80365 | 7,051 | 6,751 | $36K | |
| 82104 | 4,094 | 3,726 | $36K | |
| 82085 | 5,612 | 5,160 | $36K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,766 | 2,501 | $35K |
| 85598 | 2,944 | 2,631 | $35K | |
| 85060 | 3,823 | 3,550 | $34K | |
| 80346 | 2,703 | 2,613 | $34K | |
| 80159 | 4,318 | 3,333 | $34K | |
| 81256 | 1,853 | 1,706 | $34K | |
| 81500 | 454 | 427 | $33K | |
| 87040 | 4,110 | 3,603 | $33K | |
| 85613 | 4,430 | 3,974 | $33K | |
| G0306 | Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count | 7,489 | 6,789 | $33K |
| 86738 | 2,363 | 2,119 | $32K | |
| 80358 | 6,666 | 6,396 | $31K | |
| 87076 | 6,210 | 5,733 | $31K | |
| 80373 | 6,561 | 6,302 | $31K | |
| 80347 | 4,090 | 3,914 | $30K | |
| 82985 | 3,563 | 3,159 | $30K | |
| 86355 | 1,232 | 1,141 | $30K | |
| 80372 | 6,400 | 6,161 | $29K | |
| 84238 | 1,830 | 1,623 | $29K | |
| 87799 | 1,981 | 1,615 | $29K | |
| 84478 | 9,213 | 7,449 | $29K | |
| 88262 | 364 | 324 | $29K | |
| 83789 | 2,696 | 2,409 | $29K | |
| 82166 | 1,995 | 1,866 | $28K | |
| 86005 | 3,890 | 3,593 | $28K | |
| 88230 | 466 | 412 | $28K | |
| 83695 | 3,741 | 3,394 | $28K | |
| 86337 | 2,139 | 1,995 | $28K | |
| 81291 | 2,266 | 2,009 | $27K | |
| 85048 | 15,134 | 13,216 | $27K | |
| 82232 | 3,165 | 2,911 | $26K | |
| 85041 | 12,580 | 11,069 | $26K | |
| 80184 | 4,530 | 4,126 | $26K | |
| 82575 | 3,781 | 3,445 | $26K | |
| 82542 | 2,249 | 1,971 | $26K | |
| 87481 | 777 | 666 | $26K | |
| 87497 | 1,300 | 885 | $25K | |
| 85306 | 1,926 | 1,724 | $24K | |
| 85384 | 4,513 | 4,007 | $24K | |
| 81240 | 1,506 | 1,347 | $24K | |
| 87328 | 2,258 | 2,084 | $23K | |
| 88189 | 487 | 463 | $23K | |
| 80162 | 4,212 | 3,754 | $23K | |
| 80202 | 3,166 | 1,455 | $23K | |
| 89055 | 6,600 | 6,141 | $22K | |
| 86357 | 973 | 870 | $19K | |
| 87641 | 707 | 646 | $19K | |
| 84202 | 2,094 | 1,890 | $19K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 7,806 | 7,216 | $19K |
| 85004 | 5,255 | 4,332 | $19K | |
| 84152 | 1,505 | 1,345 | $18K | |
| 87206 | 5,003 | 3,783 | $18K | |
| 80183 | 2,576 | 2,408 | $17K | |
| 83835 | 1,371 | 1,263 | $17K | |
| 82610 | 2,206 | 2,074 | $17K | |
| 88184 | 638 | 591 | $16K | |
| 86682 | 2,351 | 2,101 | $16K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 488 | 473 | $16K |
| 87631 | 194 | 164 | $16K | |
| 82955 | 2,537 | 2,273 | $15K | |
| 83874 | 1,807 | 1,639 | $15K | |
| 85670 | 3,068 | 2,758 | $14K | |
| 83605 | 2,529 | 2,246 | $14K | |
| 86340 | 1,546 | 1,360 | $14K | |
| 82681 | 881 | 799 | $14K | |
| 84255 | 891 | 816 | $14K | |
| 87254 | 665 | 601 | $14K | |
| 85597 | 1,337 | 1,194 | $13K | |
| 82653 | 823 | 745 | $13K | |
| 85303 | 1,323 | 1,170 | $13K | |
| 87116 | 1,889 | 1,038 | $12K | |
| 85300 | 1,467 | 1,289 | $12K | |
| 83992 | 2,542 | 2,379 | $12K | |
| 82340 | 3,002 | 2,729 | $11K | |
| 83003 | 969 | 887 | $11K | |
| 36416 | 5,870 | 5,443 | $10K | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 4,717 | 4,389 | $10K |
| 81479 | Unlisted molecular pathology procedure | 317 | 274 | $10K |
| 85732 | 1,547 | 1,410 | $10K | |
| 84300 | 3,709 | 3,377 | $10K | |
| 84145 | 690 | 634 | $10K | |
| 84597 | 1,129 | 1,042 | $9K | |
| 82705 | 2,647 | 2,443 | $9K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 39 | 36 | $9K |
| 80305 | 933 | 755 | $9K | |
| 86036 | 1,484 | 1,378 | $9K | |
| 86804 | 805 | 710 | $9K | |
| 83935 | 2,172 | 2,010 | $9K | |
| 87015 | 2,093 | 1,193 | $9K | |
| 85049 | 3,303 | 2,987 | $8K | |
| 83625 | 1,070 | 950 | $8K | |
| 83930 | 1,962 | 1,797 | $8K | |
| 80356 | 970 | 754 | $8K | |
| 86880 | 2,133 | 1,931 | $8K | |
| 80364 | 2,068 | 1,940 | $8K | |
| 81270 | 289 | 253 | $7K | |
| 87109 | 804 | 700 | $7K | |
| 84140 | 587 | 514 | $7K | |
| 80201 | 979 | 916 | $7K | |
| 83088 | 417 | 354 | $7K | |
| 87106 | 1,157 | 1,077 | $7K | |
| 80158 | 726 | 564 | $7K | |
| 80198 | 1,013 | 957 | $6K | |
| 80366 | 2,524 | 2,366 | $6K | |
| 85305 | 716 | 646 | $6K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 4,462 | 4,345 | $6K |
| 83519 | 595 | 513 | $6K | |
| 86615 | 336 | 313 | $6K | |
| 80360 | 2,265 | 2,127 | $6K | |
| 80355 | 2,450 | 2,302 | $6K | |
| 82180 | 929 | 849 | $6K | |
| 80368 | 2,187 | 2,066 | $5K | |
| 80326 | 2,172 | 2,045 | $5K | |
| 87807 | 673 | 576 | $5K | |
| 85302 | 598 | 536 | $5K | |
| 80370 | 2,186 | 2,065 | $5K | |
| 87230 | 439 | 400 | $5K | |
| 82595 | 1,047 | 946 | $5K | |
| 87420 | 600 | 550 | $5K | |
| 80367 | 2,301 | 2,157 | $5K | |
| 81206 | 89 | 78 | $5K | |
| 86148 | 654 | 500 | $5K | |
| 81015 | 2,220 | 2,017 | $5K | |
| 87476 | 255 | 234 | $5K | |
| 81207 | 90 | 79 | $5K | |
| 80357 | 2,117 | 1,988 | $5K | |
| 80337 | 2,083 | 1,956 | $4K | |
| 86753 | 447 | 433 | $4K | |
| 80371 | 2,070 | 1,943 | $4K | |
| 80377 | 2,074 | 1,947 | $4K | |
| 80341 | 2,057 | 1,932 | $4K | |
| 80338 | 2,079 | 1,951 | $4K | |
| 80331 | 2,057 | 1,932 | $4K | |
| 80344 | 2,058 | 1,933 | $4K | |
| 80334 | 2,059 | 1,934 | $4K | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 3,774 | 3,416 | $4K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 33 | 33 | $3K |
| 81377 | 55 | 50 | $3K | |
| 80186 | 358 | 338 | $3K | |
| 84133 | 1,296 | 1,187 | $3K | |
| 85705 | 340 | 305 | $3K | |
| 87425 | 284 | 260 | $3K | |
| 84206 | 234 | 210 | $3K | |
| 80325 | 354 | 246 | $3K | |
| 84260 | 156 | 148 | $3K | |
| 82384 | 161 | 150 | $3K | |
| 89060 | 542 | 499 | $3K | |
| 86658 | 102 | 89 | $3K | |
| 84591 | 472 | 427 | $2K | |
| 87634 | 71 | 59 | $2K | |
| 83825 | 268 | 259 | $2K | |
| 80321 | 278 | 236 | $2K | |
| 80414 | 66 | 64 | $2K | |
| 82656 | 287 | 265 | $2K | |
| 87210 | 282 | 238 | $2K | |
| 80320 | 207 | 202 | $2K | |
| 82642 | 166 | 158 | $2K | |
| 89051 | 560 | 518 | $2K | |
| 83785 | 134 | 114 | $2K | |
| 87593 | 49 | 48 | $2K | |
| 86356 | 100 | 87 | $2K | |
| 81422 | 12 | 12 | $2K | |
| 99001 | 243 | 214 | $2K | |
| 86689 | 126 | 106 | $2K | |
| 84378 | 249 | 234 | $2K | |
| 82175 | 150 | 144 | $1K | |
| 99199 | Unlisted special service, procedure or report | 203 | 161 | $1K |
| 85549 | 122 | 115 | $1K | |
| 82523 | 271 | 229 | $1K | |
| 81002 | 645 | 581 | $1K | |
| 84442 | 137 | 130 | $1K | |
| 83631 | 131 | 125 | $1K | |
| 81402 | 33 | 25 | $1K | |
| 86215 | 138 | 126 | $1K | |
| 82507 | 128 | 121 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 22 | 18 | $1K |
| 84252 | 89 | 80 | $1K | |
| 87496 | 45 | 37 | $1K | |
| 84999 | 143 | 127 | $992.24 | |
| 87102 | 172 | 165 | $970.50 | |
| 87511 | 35 | 32 | $954.55 | |
| 85301 | 116 | 104 | $939.25 | |
| 86316 | 79 | 75 | $857.26 | |
| 81400 | 47 | 20 | $843.72 | |
| 82436 | 457 | 425 | $801.90 | |
| 83945 | 299 | 283 | $792.22 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 1,863 | 1,724 | $786.26 |
| 84163 | 78 | 73 | $747.84 | |
| 87484 | 13 | 13 | $688.81 | |
| 87252 | 36 | 36 | $670.05 | |
| 82308 | 43 | 38 | $637.21 | |
| 80195 | 120 | 102 | $626.41 | |
| 84433 | 70 | 68 | $621.48 | |
| 80235 | 72 | 70 | $607.49 | |
| 88141 | 183 | 181 | $571.01 | |
| 81332 | 51 | 48 | $565.99 | |
| 82657 | 43 | 40 | $524.40 | |
| 86710 | 41 | 35 | $501.16 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 35 | 30 | $494.00 |
| 84560 | 376 | 355 | $491.61 | |
| 87625 | 12 | 12 | $486.60 | |
| 83915 | 79 | 76 | $480.81 | |
| 81383 | 14 | 13 | $462.65 | |
| 80157 | 56 | 50 | $451.56 | |
| 82107 | 12 | 12 | $409.86 | |
| 84105 | 318 | 301 | $350.72 | |
| 82010 | 74 | 65 | $326.58 | |
| 81338 | 14 | 14 | $316.26 | |
| 87486 | 16 | 14 | $314.43 | |
| 87581 | 16 | 14 | $314.43 | |
| 82540 | 105 | 101 | $311.08 | |
| 86606 | 14 | 14 | $273.38 | |
| 84540 | 134 | 126 | $263.27 | |
| 83986 | 316 | 298 | $231.71 | |
| 84392 | 119 | 112 | $226.18 | |
| 80145 | 13 | 13 | $211.35 | |
| 81219 | 13 | 13 | $197.05 | |
| 80203 | 26 | 25 | $196.14 | |
| 83529 | 26 | 25 | $187.56 | |
| 80345 | 22 | 17 | $177.94 | |
| 87468 | 15 | 12 | $166.38 | |
| 86022 | 16 | 12 | $155.09 | |
| 81050 | 119 | 112 | $149.96 | |
| 82615 | 90 | 88 | $148.51 | |
| 82608 | 12 | 12 | $132.27 | |
| 85220 | 15 | 14 | $129.73 | |
| 87207 | 38 | 28 | $122.63 | |
| 87899 | 15 | 12 | $77.02 | |
| 80323 | 12 | 12 | $73.72 | |
| 86041 | 14 | 13 | $57.80 | |
| 86161 | 15 | 13 | $52.73 | |
| 86309 | 13 | 12 | $48.05 | |
| Z9999 | 30 | 12 | $0.00 | |
| 80375 | 25 | 12 | $0.00 | |
| 81327 | 60 | 50 | $0.00 |